Latest Articles

  • Recognizing and managing hereditary angioedema
    Recognizing and managing hereditary angioedema
    Kevin Tse, MD and Bruce L. Zuraw, MD
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 297-308; DOI: https://doi.org/10.3949/ccjm.80a.12073

    Recognizing this rare but life-threatening disease is crucial, especially now that drugs are available to prevent and treat acute attacks.

  • Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events
    Ki Park, MD and Anthony A. Bavry, MD, MPH
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 318-326; DOI: https://doi.org/10.3949/ccjm.80a.12146

    Aspirin’s benefits in primary prevention are not as clear as in secondary prevention, particularly in people with diabetes, in women, and in the elderly.

  • Preserving fertility in female cancer patients: A snapshot of the options
    Ilaria Soave, MD, Giuseppe Lo Monte, MD, Emilio Giugliano, MD, Angela Graziano, MD and Roberto Marci, PhD
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 309-317; DOI: https://doi.org/10.3949/ccjm.80a.12065

    With the odds of surviving cancer improving, many young women facing therapy may first wish to take steps to ensure that they will still be able to bear children afterward.

  • A review of uncommon swelling provides useful reminders
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 261; DOI: https://doi.org/10.3949/ccjm.80b.05013

    Angioedema and the urticarias differ in their clinical manifestations and diagnostic and therapeutic implications.

  • Hyperpigmented patches on the neck, shoulder, and back
    Jason M. Rizzo, BS, Lesley C. Loss, MD and Ilene L. Rothman, MD
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 290-296; DOI: https://doi.org/10.3949/ccjm.80a.12033

    A 17-year-old boy has had asymptomatic, unilateral hyperpigmented patches since birth. What is the diagnosis?

  • Detecting and controlling diabetic nephropathy: What do we know?
    Gerald Appel, MD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 209-217; DOI: https://doi.org/10.3949/ccjm.80gr.12006

    Diabetic kidney disease is on the rise. Strategies to prevent or control it are lowering blood pressure, controlling blood sugar, and inhibiting the renin-angiotensin-aldosterone system.

  • Resistance of man and bug
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 202; DOI: https://doi.org/10.3949/ccjm.80b.04013

    Why individual clinicians make specific decisions usually can be sorted out. But our behavior as a group is more difficult to understand—and to alter.

  • In Reply: Short QT syndrome (January 2013)
    Hayan Al Maluli, MD and Arnold B. Meshkov, MD, MBA, FACC
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 203; DOI: https://doi.org/10.3949/ccjm.80c.04002

    Readers comment on the short QT syndrome (January 2013).

  • What should be the interval between bone density screenings?
    Susan M. Ott, MD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 240-242; DOI: https://doi.org/10.3949/ccjm.80a.12166

    Doctors should not order unnecessary and expensive tests and should not recommend frequent repeated testing that does not benefit the patient.

  • Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients
    Federico Perez, MD and David Van Duin, MD, PhD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 225-233; DOI: https://doi.org/10.3949/ccjm.80a.12182

    The emergence of carbapenem-resistant Enterobacteriaceae (CRE) highlights the importance of effective antibiotics to maintain the safety of our health care system. Clinicians will encounter CRE as a cause of difficult-to-treat and often fatal infections in hospitalized patients. We review the mechanisms of carbapenem resistance, the dissemination and clinical impact of these resistant organisms, and challenges to their detection, treatment, and control.

Pages